The Trump administration is targeting pharmaceutical companies with an executive order aimed at lowering U.S. drug prices ...

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...

Noom will start offering microdoses of compounded Wegovy (NVO), the blockbuster weight-loss drug, as the digital health ...

Viking Therapeutics offers leaner operations, lower complexity, faster trial execution, and less execution risk. Learn more ...

Purdue University is launching new academic programs, expanding research capabilities and forging partnerships with one ...

Lilly-Ella Gerrard, the daughter of football legend Steven Gerrard, has given a huge update on her pregnancy as she showed ...

The Tobias-Lechleiter Institute for Clinical Innovation will serve as a hub for "groundbreaking" disease detection and ...

Bucks County, Pa. has initiated legal proceedings against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated effort to inflate ...

As Eli Lilly and Novo Nordisk continue to go in opposite directions in their diabetes and obesity market rivalry, so too have they changed positions in the annual IDEA Pharma Innovation Index, which ...

Eli Lilly (NYSE: LLY) is encouraged by trial data for its latest weight-loss and diabetes medications. Where to invest $1,000 ...

The London Biotechnology Show returns for its highly anticipated second edition, building on the remarkable success of its ...

The Dementia Discovery Fund ("DDF"), managed by SV Health Investors, today announced the final closing of its second fund, DDF-2, with $269m in commitments. DDF is the world's largest family of ...